80 filings
8-K
ITRM
Iterum Therapeutics Plc
10 May 24
Departure of Directors or Certain Officers
4:15pm
8-K
ITRM
Iterum Therapeutics Plc
29 Apr 24
Other Events
4:30pm
8-K
ITRM
Iterum Therapeutics Plc
5 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
ITRM
Iterum Therapeutics Plc
29 Mar 24
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
7:15am
8-K
ITRM
Iterum Therapeutics Plc
6 Mar 24
Iterum Therapeutics Provides Business Update
8:16am
8-K
l3g2 vtmpj148p
30 Jan 24
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
dapx xxtwz
30 Jan 24
Regulation FD Disclosure
7:15am
8-K
a0kwm4ppf690z3smbv
29 Dec 23
Departure of Directors or Certain Officers
4:30pm
8-K
jva3 vqhs23yt102w
4 Dec 23
Other Events
8:30am
8-K
zopwjxnp
14 Nov 23
Iterum Therapeutics Reports Third Quarter 2023 Financial Results
12:00am
8-K
iabfc499
24 Oct 23
Other Events
9:00am
8-K
dixu7e4tle6ppfthd
29 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:00pm
8-K
wlnugv4 dscv1p
11 Aug 23
Iterum Therapeutics Reports Second Quarter 2023 Financial Results
7:15am
8-K
8rz6zu3
1 Aug 23
Submission of Matters to a Vote of Security Holders
4:16pm
8-K
azrp5vfq4e4ziy1oyf3i
12 May 23
Iterum Therapeutics Reports First Quarter 2023 Financial Results
12:00am
8-K
9bhgwvkqrg5ywi7axy6
4 May 23
Material Modifications to Rights of Security Holders
1:26pm
8-K
fyhi hupko
16 Mar 23
Iterum Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
7:16am
8-K
bv573wb9 8d
17 Feb 23
Other Events
4:31pm
8-K
m1q6abiu89n2r9c7k4t
15 Dec 22
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
4:31pm
8-K
dhbz6
10 Nov 22
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
7:15am